Commercialization Challenges for Cell and Gene Therapies

Commercialization Challenges for Cell and Gene Therapies

04/28/2020, 10:30 AM - 12:00 PM

Innovation Stage, Booth 1281, Exhibit Hall
The early promise offered by cell therapies and gene therapies is tempered by the challenges associated with developing, manufacturing, and delivering the drug product to patients. The complexities of producing these therapies are testing established practices, from starting materials—to process development—to cGMP compliance—to supply chain security and reliability. This session will highlight technical and regulatory hurdles associated with development and manufacturing steps, and strategies and solutions to facilitate development through commercialization steps. The discussion will include a focus on data management and scheduling strategies to guarantee transparency and chains of authenticity and custody for personalized therapies.

Type of Session

  1. Type of Session


  1. Track
    Keynote Series

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.